Acadia Pharmaceuticals

1 Follower


As a leader in developing and commercializing innovative therapies for central nervous system disorders we are committed to improving the lives of patients.

Stephen R. Davis
President & CEO
Stephen R. Davis
Serge Stankovic
Amanda Morgan
SVP, Chief Revenue and Customer Officer
Austin D. Kim
EVP, General Counsel & Secretary
Bob Mischler
SVP Strategy and Technology Operations
Charmaine Lykins
SVP, Global Product Planning and Chief Marketing Officer
Daryl Dekarske
SVP, Global Head of Regulatory Affairs and Head of Translational Sciences
Elena Ridloff
Mary Ellen Turner
Senior Vice President, Pharmacovigilance and Corporate Safety Officer
Stephanie Fagan
SVP Corporate Affairs & Chief Communications Officer
Gudarz Davar
EVP & Head of Research and Development
Mark Schneyer
SVP, Business Development and Chief Business Officer
Brendan Teehan
SVP, Chief Insights & Analytics Officer
Diann Potestio
SVP, Global Market Access, Reimbursement & Distribution
Kathie M. Bishop
SVP, Head of Rare Disease and External Innovation

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.